Covaxin Gets Approval For Restricted Emergency Use In Children Aged 6-12 Years

Mumbai: Drugs Controller General of India (DCGI) has granted restricted emergency use authorisation to Bharat Biotech’s Covaxin for children between the age of 6-and 12 years.

Besides, the drug regulator also granted emergency use authorization to Corbevax for children between the age of 5-and 12 years and ZycovD (Zydus Cadila vaccine) for children above the age of 12 years.

As of now, India has not begun vaccinating children below 15 years. For the unversed, the country started inoculating children in the 12-14 age group against Covid on March 16.

“If children are safe, the country is safe. It makes me really happy to announce that from March 16, children in (the) 12-14 age group can get vaccinated against Covid,” health minister Mansukh Mandaviya had tweeted, announcing the government’s decision to expand COVID-19 vaccination for 12-13 years and 13-14 years.

https://twitter.com/mansukhmandviya/status/1518863947386224641?s=20&t=bf7N7Ytt5LUuD_0X2oMI1w

Earlier this month, National Institute of Virology (NIV) director Dr Priya Abraham had said that there was a need to vaccinate children below 12 years of age.

“Children below the age of 12 years who are at high risk — as in those who are on dialysis, have immunosuppression and also are suffering from cancer, among others — need to be vaccinated,” she had told a news agency PTI.

Follow us on Twitter, and Instagram, and like us on Facebook for the latest updates and interesting stories.